Our research highlights how businesses are responding:
- Governments are adopting policies aiming to transform healthcare delivery by integrating technology and digital solutions and redesigning services to reduce inequalities and improve patient experience.
- Pharmaceutical and life sciences companies are actively investing in research enabling the development of cutting-edge treatments and therapies that are tailored and personalised to the unique genetic makeup of each patient.
- The consumer health sector is redoubling its efforts to promote self-care and health literacy, make more products accessible over-the-counter and harness the opportunities of health tech.
Meet some of our team
Pamela is a life sciences value creation, strategic growth and acquisition advisory specialist focused on delivering impressive outcomes for businesses, their employees and their customers. She has a PhD in medical sciences and an executive MBA (both from the University of Oxford). Her career spans drug development, strategy and management consulting within the global healthcare and pharmaceutical arenas.
With a wealth of experience in the consumer health sector, Jon has a track record of delivering in complex engagements, including global transformations and M&A (mergers, acquisitions, divestments and separations), where he has been instrumental in driving maximum value realisation for his clients. Jon’s leadership and delivery expertise spans a range of areas from people aspects (culture, employee experience and change management) to cross-functional programme implementation, system integration and more.
Grace has extensive business transformation experience and a strong track record in strategic design and program delivery in complex operational and asset-intensive environments. She has worked in both the public and private sectors, working closely with senior leaders in organizations including NHS England, NHS Trusts, Clinical Commissioning Groups, Bank of England, BT, GE and HS2 Rail.
